CA3025063A1 - Mutants de degradation du proteoglycane pour le traitement du systeme nerveux central - Google Patents
Mutants de degradation du proteoglycane pour le traitement du systeme nerveux centralInfo
- Publication number
- CA3025063A1 CA3025063A1 CA3025063A CA3025063A CA3025063A1 CA 3025063 A1 CA3025063 A1 CA 3025063A1 CA 3025063 A CA3025063 A CA 3025063A CA 3025063 A CA3025063 A CA 3025063A CA 3025063 A1 CA3025063 A1 CA 3025063A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- chondroitinase
- composition
- polypeptide
- deletion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47123903P | 2003-05-16 | 2003-05-16 | |
US47124003P | 2003-05-16 | 2003-05-16 | |
US60/471,239 | 2003-05-16 | ||
US60/471,240 | 2003-05-16 | ||
US60/471,300 | 2003-05-16 | ||
US47437203P | 2003-05-29 | 2003-05-29 | |
US60/474,372 | 2003-05-29 | ||
CA2525784A CA2525784C (fr) | 2003-05-16 | 2004-05-17 | Mutants de degradation du proteoglycane pour le traitement du systeme nerveux central |
US47130005P | 2005-05-16 | 2005-05-16 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2525784A Division CA2525784C (fr) | 2003-05-16 | 2004-05-17 | Mutants de degradation du proteoglycane pour le traitement du systeme nerveux central |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3025063A1 true CA3025063A1 (fr) | 2004-12-23 |
Family
ID=64456681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3025063A Abandoned CA3025063A1 (fr) | 2003-05-16 | 2004-05-17 | Mutants de degradation du proteoglycane pour le traitement du systeme nerveux central |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA3025063A1 (fr) |
-
2004
- 2004-05-17 CA CA3025063A patent/CA3025063A1/fr not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9528102B2 (en) | Proteoglycan degrading mutants for treatment of CNS | |
EP2354155A2 (fr) | Protéines de fusion pour le traitement du SNC | |
AU2016204464B2 (en) | Proteoglycan degrading mutants for treatment of cns | |
AU2013201097B2 (en) | Proteoglycan degrading mutants for treatment of cns | |
CA3025063A1 (fr) | Mutants de degradation du proteoglycane pour le traitement du systeme nerveux central | |
AU2014265113A1 (en) | Fusion proteins for the treatment of cns |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20190521 |
|
FZDE | Discontinued |
Effective date: 20220311 |
|
FZDE | Discontinued |
Effective date: 20220311 |